Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes

Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes

Bibliographic Details
Main Authors:	Haidar, Ahmad, Elleri, Daniela, Kumareswaran, Kavita, Leelarathna, Lalantha, Allen, Janet M., Caldwell, Karen, Murphy, Helen R., Wilinska, Malgorzata E., Acerini, Carlo L., Evans, Mark L., Dunger, David B., Nodale, Marianna, Hovorka, Roman
Format:	Online
Language:	English
Published:	American Diabetes Association 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781562/

Similar Items

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
by: Elleri, Daniela, et al.
Published: (2013)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
by: Hovorka, Roman, et al.
Published: (2014)

Safety, efficacy and glucose turnover of reduced prandial boluses during closed‐loop therapy in adolescents with type 1 diabetes: a randomized clinical trial
by: Elleri, D., et al.
Published: (2015)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
by: Leelarathna, Lalantha, et al.
Published: (2013)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
by: Barnard, Katharine D, et al.
Published: (2014)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
by: Ruan, Yue, et al.
Published: (2014)

Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes: A randomized crossover case series
by: Murphy, Helen R., et al.
Published: (2011)

Closed-loop insulin delivery for treatment of type 1 diabetes
by: Elleri, Daniela, et al.
Published: (2011)

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
by: Hovorka, Roman, et al.
Published: (2011)

Physical Activity Energy Expenditure and Glucose Control in Pregnant Women With Type 1 Diabetes: Is 30 minutes of daily exercise enough?
by: Kumareswaran, Kavita, et al.
Published: (2013)

Validity of triple- and dual-tracer techniques to estimate glucose appearance
by: Haidar, A., et al.
Published: (2012)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
by: Thabit, Hood, et al.
Published: (2016)

Continuous glucose monitoring in critically ill adults: comparison of two different calibration protocols
by: Leelarathna, L, et al.
Published: (2013)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
by: Tauschmann, Martin, et al.
Published: (2015)

Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial
by: Tauschmann, Martin, et al.
Published: (2016)

Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management
by: Luijf, Yoeri M., et al.
Published: (2013)

Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart
by: Goudie, Robert J. B., et al.
Published: (2015)

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
by: Elleri, Daniela, et al.
Published: (2014)

Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
by: Tauschmann, Martin, et al.
Published: (2016)

Unsupervised home use of an overnight closed‐loop system over 3–4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes
by: Thabit, H., et al.
Published: (2015)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
by: Adler, Amanda I., et al.
Published: (2011)

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery
by: Ruan, Yue, et al.
Published: (2015)

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol
by: Leelarathna, Lalantha, et al.
Published: (2014)

Restoration of Self-Awareness of Hypoglycemia in Adults With Long-Standing Type 1 Diabetes: Hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial
by: Leelarathna, Lalantha, et al.
Published: (2013)

Insulin aspart in patients with gestational diabetes mellitus and pregestational diabetes mellitus
by: Deepaklal, M. C., et al.
Published: (2015)

Measurement delay associated with the Guardian® RT continuous glucose monitoring system
by: Wei, C, et al.
Published: (2010)

Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
by: Heise, T., et al.
Published: (2015)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
by: Shin, Jai Moo, et al.
Published: (2013)

Coming of age: the artificial pancreas for type 1 diabetes
by: Thabit, Hood, et al.
Published: (2016)

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience
by: Hermansen, Kjeld, et al.
Published: (2015)

Aspartate Aminotransferase – Risk Marker for Type-2 Diabetes Mellitus or Red Herring?
by: Kunutsor, Setor K., et al.
Published: (2014)

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes
by: Bolli, G B, et al.
Published: (2011)

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions
by: Thabit, Hood, et al.
Published: (2015)

Influence of the Duration of Diabetes on the Outcome of a Diabetes Self-Management Education Program
by: Ko, Seung-Hyun, et al.
Published: (2012)

Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control
by: Nisar, Muhammad Umer, et al.
Published: (2015)

Change in Sleep Duration and Type 2 Diabetes: The Whitehall II Study
by: Ferrie, Jane E., et al.
Published: (2015)

Insulin pump therapy in transient neonatal diabetes mellitus
by: Park, Joong Heum, et al.
Published: (2013)

Impact of insulin pump on quality of life of diabetic patients
by: Ghazanfar, Haider, et al.
Published: (2016)

Reducing Bias in Auditory Duration Reproduction by Integrating the Reproduced Signal
by: Shi, Zhuanghua, et al.
Published: (2013)

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial
by: Niskanen, Leo, et al.
Published: (2012)